According to our (Global Info Research) latest study, the global Residual Undifferentiated Cell Detection Kit market size was valued at US$ 43.22 million in 2025 and is forecast to a readjusted size of US$ 122 million by 2032 with a CAGR of 15.5% during review period.
Residual undifferentiated cell detection kits are quality-control reagent systems used to identify and quantify residual human pluripotent stem cells or undifferentiated iPSC/ESC cells in differentiated cell products. They are typically based on qPCR/ddPCR, flow cytometry, immunocytochemistry, live-cell lectin probes, or high-efficiency culture-enrichment assays, and detect markers such as LIN28A, ESRG, LINC00678, TRA-1-60, SSEA-4, OCT4, SOX2, NANOG, and rBC2LCN-binding glycans. They are mainly used in process development, in-process control, release testing, and tumorigenicity risk assessment for iPSC-derived cell therapy products, with high sensitivity, low background, quantifiability, and assay validation by differentiated cell type; the blended gross margin is about 65%.
Demand is mainly driven by the clinical progression and scale-up of iPSC-derived cardiomyocyte, islet, neural, retinal, immune-cell, and other cell products. As cell therapies move from research validation to batch manufacturing, residual undifferentiated cells are becoming a critical safety attribute related to tumorigenicity risk, batch release, and regulatory communication, making customers prefer validated, transferable, SOP-ready kit-based solutions.
Product development is shifting from single-marker assays such as OCT4 or TRA-1-60 toward multi-marker panels, high-sensitivity ddPCR quantification, live-cell probes, enrichment culture, and automated imaging or flow-cytometry workflows. Large research-reagent suppliers mainly provide general marker panels, while specialist companies and CROs provide residual PSC quantification services; competition will focus on marker suitability, limit of detection, matrix-interference control, and inter-laboratory consistency.
Demand is concentrated in the United States, Europe, Japan, and China, where iPSC therapy development is active. In the near term, adoption is affected by the number of clinical programs, validation cost, and customers’ in-house testing capability, while long-term opportunities come from stricter regulatory expectations, increased outsourcing of release testing, and growing need for GMP-compatible reagents and customized marker panels.
Report Scope
This report is a detailed and comprehensive analysis for global Residual Undifferentiated Cell Detection Kit market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Residual Undifferentiated Cell Detection Kit market size and forecasts, in consumption value ($ Million), sales quantity (Units), and average selling prices (US$/Unit), 2021-2032
Global Residual Undifferentiated Cell Detection Kit market size and forecasts by region and country, in consumption value ($ Million), sales quantity (Units), and average selling prices (US$/Unit), 2021-2032
Global Residual Undifferentiated Cell Detection Kit market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (Units), and average selling prices (US$/Unit), 2021-2032
Global Residual Undifferentiated Cell Detection Kit market shares of main players, shipments in revenue ($ Million), sales quantity (Units), and ASP (US$/Unit), 2021-2026
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Residual Undifferentiated Cell Detection Kit
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Residual Undifferentiated Cell Detection Kit market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Thermo Fisher Scientific, FUJIFILM Wako Pure Chemical, Sistemic, Bio-Techne, BD Biosciences, Miltenyi Biotec, Merck, Abcam, STEMCELL Technologies, Takara Bio, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
Residual Undifferentiated Cell Detection Kit market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Nucleic Acid Amplification Kits
Flow Cytometry Kits
Immunocytochemistry Kits
Live-Cell Probe Kits
Cell Enrichment and Culture Assay Kits
Market segment by Marker Strategy
Gene Expression Marker Kits
MicroRNA Marker Kits
Surface Antigen Marker Kits
Intracellular Protein Marker Kits
Lectin and Glycan Probe Kits
Colony Formation Readout Kits
Market segment by Testing Stage
Final Product Testing Kits
In-Process Testing Kits
Cell Bank Testing Kits
Reprogramming Culture Testing Kits
Mixed Population Testing Kits
Market segment by Validation Level
Research Use Only Kits
Process Development QC Kits
GMP-Compatible QC Kits
Validated Assay Service Kits
Custom Marker Panel Kits
Market segment by Application
iPSC-Derived Cell Therapy Release Testing
In-Process Differentiation Monitoring
Stem Cell Culture Quality Control
Tumorigenicity Risk Assessment
Assay Development and Validation
Academic and Translational Research
Major players covered
Thermo Fisher Scientific
FUJIFILM Wako Pure Chemical
Sistemic
Bio-Techne
BD Biosciences
Miltenyi Biotec
Merck
Abcam
STEMCELL Technologies
Takara Bio
Market segment by region, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
Chapter Outline
Chapter 1, to describe Residual Undifferentiated Cell Detection Kit product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Residual Undifferentiated Cell Detection Kit, with price, sales quantity, revenue, and global market share of Residual Undifferentiated Cell Detection Kit from 2021 to 2026.
Chapter 3, the Residual Undifferentiated Cell Detection Kit competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Residual Undifferentiated Cell Detection Kit breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2021 to 2032.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2021 to 2032.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2021 to 2026.and Residual Undifferentiated Cell Detection Kit market forecast, by regions, by Type, and by Application, with sales and revenue, from 2027 to 2032.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Residual Undifferentiated Cell Detection Kit.
Chapter 14 and 15, to describe Residual Undifferentiated Cell Detection Kit sales channel, distributors, customers, research findings and conclusion.
Summary:
Get latest Market Research Reports on Residual Undifferentiated Cell Detection Kit. Industry analysis & Market Report on Residual Undifferentiated Cell Detection Kit is a syndicated market report, published as Global Residual Undifferentiated Cell Detection Kit Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032. It is complete Research Study and Industry Analysis of Residual Undifferentiated Cell Detection Kit market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.